Chronic fatigue syndrome and epigenetics: The case for hyperbaric oxygen therapy in biomarker identification
Open Access
- 26 February 2021
- journal article
- Published by Heighten Science Publications Corporation in Journal of Pulmonology and Respiratory Research
- Vol. 5 (1), 027-030
- https://doi.org/10.29328/journal.jprr.1001020
Abstract
Chronic fatigue syndrome (CFS) is a poorly-understood respiratory condition that affects millions of individuals. Hyperbaric oxygen therapy (HBOT) is a treatment option being considered to address CFS as it is suggested to combat fatigue and increase oxygenation. HBOT provides two opportunities in advancing research of CFS: it may provide data on symptom amelioration and be utilized in the search for a biomarker. By either identifying biomarkers before using HBOT to compare epigenomes of patients before and after treatment or using HBOT to find epigenetic discrepancies between patients with and without treatment, matching epigenetic regulation with symptom amelioration may significantly advance the understanding of the etiology and treatment mechanism for CFS. EPAS1/HIF-2α is a leading candidate for an epigenetic biomarker as it responds differentially to hypoxic and normoxic conditions, which degrades more slowly in hypoxic conditions. Epigenetic regulation of EPAS1/HIF-2α in such differential conditions may be explored in HBOT experiments. In addition to HBOT as a promising treatment option for CFS symptoms, it may aid the identification of biomarkers in CFS. Further research into both outcomes is strongly encouraged.Keywords
This publication has 17 references indexed in Scilit:
- A novel distal upstream hypoxia response element regulating oxygen-dependent erythropoietin gene expressionHaematologica, 2014
- Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosisHuman Molecular Genetics, 2013
- A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paragangliomaJournal of Molecular Medicine, 2012
- A formal analysis of cytokine networks in Chronic Fatigue SyndromeBrain, Behavior, and Immunity, 2010
- Natural selection on EPAS1 ( HIF2α ) associated with low hemoglobin concentration in Tibetan highlandersProceedings of the National Academy of Sciences of the United States of America, 2010
- The Genetics and Epigenetics of FatiguePM&R, 2010
- Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue SyndromeScience, 2009
- The EPAS1 gene influences the aerobic–anaerobic contribution in elite endurance athletesHuman Genetics, 2005
- Hyperbaric Therapy in Chronic Fatigue SyndromeJournal of Chronic Fatigue Syndrome, 2003
- Circulating Blood Volume in Chronic Fatigue SyndromeJournal of Chronic Fatigue Syndrome, 1998